These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
322 related articles for article (PubMed ID: 12594848)
1. Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein. Welte SA; Sinzger C; Lutz SZ; Singh-Jasuja H; Sampaio KL; Eknigk U; Rammensee HG; Steinle A Eur J Immunol; 2003 Jan; 33(1):194-203. PubMed ID: 12594848 [TBL] [Abstract][Full Text] [Related]
2. Effects of human cytomegalovirus infection on ligands for the activating NKG2D receptor of NK cells: up-regulation of UL16-binding protein (ULBP)1 and ULBP2 is counteracted by the viral UL16 protein. Rölle A; Mousavi-Jazi M; Eriksson M; Odeberg J; Söderberg-Nauclér C; Cosman D; Kärre K; Cerboni C J Immunol; 2003 Jul; 171(2):902-8. PubMed ID: 12847260 [TBL] [Abstract][Full Text] [Related]
3. Down-regulation of the NKG2D ligand MICA by the human cytomegalovirus glycoprotein UL142. Chalupny NJ; Rein-Weston A; Dosch S; Cosman D Biochem Biophys Res Commun; 2006 Jul; 346(1):175-81. PubMed ID: 16750166 [TBL] [Abstract][Full Text] [Related]
4. Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity. Dunn C; Chalupny NJ; Sutherland CL; Dosch S; Sivakumar PV; Johnson DC; Cosman D J Exp Med; 2003 Jun; 197(11):1427-39. PubMed ID: 12782710 [TBL] [Abstract][Full Text] [Related]
5. TGF-beta and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells. Eisele G; Wischhusen J; Mittelbronn M; Meyermann R; Waldhauer I; Steinle A; Weller M; Friese MA Brain; 2006 Sep; 129(Pt 9):2416-25. PubMed ID: 16891318 [TBL] [Abstract][Full Text] [Related]
6. Soluble ULBP suppresses natural killer cell activity via down-regulating NKG2D expression. Song H; Kim J; Cosman D; Choi I Cell Immunol; 2006 Jan; 239(1):22-30. PubMed ID: 16630603 [TBL] [Abstract][Full Text] [Related]
7. Differential NKG2D binding to highly related human NKG2D ligands ULBP2 and RAET1G is determined by a single amino acid in the alpha2 domain. Wittenbrink M; Spreu J; Steinle A Eur J Immunol; 2009 Jun; 39(6):1642-51. PubMed ID: 19424970 [TBL] [Abstract][Full Text] [Related]
8. Proteolytic release of soluble UL16-binding protein 2 from tumor cells. Waldhauer I; Steinle A Cancer Res; 2006 Mar; 66(5):2520-6. PubMed ID: 16510567 [TBL] [Abstract][Full Text] [Related]
9. Cell surface organization of stress-inducible proteins ULBP and MICA that stimulate human NK cells and T cells via NKG2D. Eleme K; Taner SB; Onfelt B; Collinson LM; McCann FE; Chalupny NJ; Cosman D; Hopkins C; Magee AI; Davis DM J Exp Med; 2004 Apr; 199(7):1005-10. PubMed ID: 15051759 [TBL] [Abstract][Full Text] [Related]
10. Intracellular retention of the MHC class I-related chain B ligand of NKG2D by the human cytomegalovirus UL16 glycoprotein. Wu J; Chalupny NJ; Manley TJ; Riddell SR; Cosman D; Spies T J Immunol; 2003 Apr; 170(8):4196-200. PubMed ID: 12682252 [TBL] [Abstract][Full Text] [Related]
11. Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate. Armeanu S; Bitzer M; Lauer UM; Venturelli S; Pathil A; Krusch M; Kaiser S; Jobst J; Smirnow I; Wagner A; Steinle A; Salih HR Cancer Res; 2005 Jul; 65(14):6321-9. PubMed ID: 16024634 [TBL] [Abstract][Full Text] [Related]
12. ULBP1, 2, 3: novel MHC class I-related molecules that bind to human cytomegalovirus glycoprotein UL16, activate NK cells. Kubin M; Cassiano L; Chalupny J; Chin W; Cosman D; Fanslow W; Müllberg J; Rousseau AM; Ulrich D; Armitage R Eur J Immunol; 2001 May; 31(5):1428-37. PubMed ID: 11465099 [TBL] [Abstract][Full Text] [Related]
13. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Cosman D; Müllberg J; Sutherland CL; Chin W; Armitage R; Fanslow W; Kubin M; Chalupny NJ Immunity; 2001 Feb; 14(2):123-33. PubMed ID: 11239445 [TBL] [Abstract][Full Text] [Related]
14. Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity. Pende D; Rivera P; Marcenaro S; Chang CC; Biassoni R; Conte R; Kubin M; Cosman D; Ferrone S; Moretta L; Moretta A Cancer Res; 2002 Nov; 62(21):6178-86. PubMed ID: 12414645 [TBL] [Abstract][Full Text] [Related]
15. Structure of the HCMV UL16-MICB complex elucidates select binding of a viral immunoevasin to diverse NKG2D ligands. Müller S; Zocher G; Steinle A; Stehle T PLoS Pathog; 2010 Jan; 6(1):e1000723. PubMed ID: 20090832 [TBL] [Abstract][Full Text] [Related]
16. [Expression of NKG2D ligands on dendritic cells at different development stages and its effect on cytotoxicity of NK cells]. Tu SF; Guo KY; Hu LS; Mei JZ; Zhou J; Sun M Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Apr; 24(4):341-3, 347. PubMed ID: 18394338 [TBL] [Abstract][Full Text] [Related]
17. The UL16-binding proteins, a novel family of MHC class I-related ligands for NKG2D, activate natural killer cell functions. Sutherland CL; Chalupny NJ; Cosman D Immunol Rev; 2001 Jun; 181():185-92. PubMed ID: 11513139 [TBL] [Abstract][Full Text] [Related]
18. Human cytomegalovirus-encoded UL16 discriminates MIC molecules by their alpha2 domains. Spreu J; Stehle T; Steinle A J Immunol; 2006 Sep; 177(5):3143-9. PubMed ID: 16920952 [TBL] [Abstract][Full Text] [Related]